Cargando…
Targeting Homeostatic T Cell Proliferation to Control Beta-Cell Autoimmunity
Immunomodulation of the autoreactive T cell response is considered a major strategy to control beta-cell autoimmunity, both in the natural history of type 1 diabetes and in islet transplantation, which can be affected by autoimmunity recurrence. So far, these strategies have had modest results, prom...
Autores principales: | Vignali, Debora, Monti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794519/ https://www.ncbi.nlm.nih.gov/pubmed/26983628 http://dx.doi.org/10.1007/s11892-016-0731-9 |
Ejemplares similares
-
T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity
por: Bordignon, Carlotta, et al.
Publicado: (2017) -
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications
por: Mangialardi, Giuseppe, et al.
Publicado: (2016) -
GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass
por: Eriksson, Olof
Publicado: (2019) -
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
por: McLaughlin, Rene J., et al.
Publicado: (2016) -
Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
por: Nijhoff, Michiel F., et al.
Publicado: (2018)